VIDA THERAPEUTICS INC has a total of 24 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2014. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are BIOSYNTHEMA INC, VHSQUARED LTD and CSL Behring Lengnau AG.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 12 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | Canada | 4 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | Australia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Specific use of cosmetics | |
#5 | Syringes | |
#6 | Heterocyclic compounds | |
#7 | Object sterilising |
# | Name | Total Patents |
---|---|---|
#1 | Cameron Dale R | 24 |
#2 | Granville David | 2 |
#3 | Estrada Maria Fernanda Zuluaga | 2 |
#4 | Shen Yue | 2 |
#5 | Boey Anthony S K | 2 |
Publication | Filing date | Title |
---|---|---|
US2019038602A1 | Granzyme b inhibitor formulations and methods for the treatment of burns | |
US2016083422A1 | Indoline compounds as granzyme B inhibitors | |
WO2016015159A1 | Azaindoline compounds as granzyme b inhibitors | |
US9458193B1 | Proline compounds as Granzyme B inhibitors | |
US9458192B1 | Covalent granzyme B inhibitors | |
US9458138B1 | Pyrrole compounds as granzyme B inhibitors | |
EP3186270A1 | Cyclic urea compounds as granzyme b inhibitors | |
WO2014153667A1 | Cosmetic uses and methods for indoline granzyme b inhibitor compositions |